The Irish duo opened a new creative chapter this year with two diverse projects that brought them to the Arctic and back to ...

The new Kronos IEMs from have nine drivers and a six-way crossover but an impedance of less than 35Ω. Noble Audio has announced the launch of its latest pair of flagship in-ear monitors. The Kronos ...

Kronos is a HOLD: TiO2 demand should rise, but KRO lacks operating leverage and control over key feedstocks to benefit from upside. KRO faces significant competition from Chinese producers, especially ...

CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. ("Kronos Bio") (Nasdaq: KRON), a biotechnology company that has been developing small molecule therapeutics to address cancers and ...

Kronos Bio is vacating its corporate headquarters amid a wider cost-cutting exercise for the struggling biotech. The company, which has been focused on developing small-molecule drugs for cancers and ...

Performances in N.Y.C. Advertisement Supported by The venerable quartet returned to Zankel Hall with a typically eclectic program and a newfound emotional intensity. By Corinna da Fonseca-Wollheim The ...

Big names returned to the annual National Association of Music Merchants Show in 2025, bringing with them a plethora of musical products from the old school to the futuristic. Companies like Boss, ...

NAMM 2025: Korg has revived its beloved Kronos workstation, unveiling an updated model that promises to be faster and more flexible then previous incarnations, as well as being packed with fresh ...

New more versatile sound engine. Vocoder, hardtune and harmonizer vocal effects. Solid build. Excellent color screen. The MicroKorg 2 is an improvement on the original in almost every way, that much ...

Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

Kronos Worldwide, Inc. KRO recently announced that it acquired a 50% joint venture interest in Louisiana Pigment Company, L.P. (“LPC”). It was previously held by Venator Investments, Ltd. Kronos, ...

Kronos Bio has made its second round of layoffs in five months, with another fifth of the biotech’s workforce heading to the exits as the company focuses on a CDK9 inhibitor. Laying off 21% of staff ...